New pain combo aims to get bowels moving faster after surgery
NCT ID NCT07651722
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of a long-lasting numbing drug (liposomal bupivacaine) injected into the belly wall plus a special painkiller (oxycodone) given through an IV can help the gut recover faster after major abdominal surgery. 132 adults having small bowel or colorectal surgery will be randomly assigned to one of three pain treatment groups. The main goal is to see if this combo improves bowel function in the first week after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
liposomal bupivacaine and oxycodone
What this could lead to
If it works, this could lead to a standard pain management plan that helps patients recover bowel function faster after abdominal surgery.
What could go wrong
This is a small, early-phase trial at one hospital, so results may not apply to everyone. The new drug combo may not work better than current options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Tianjin First Central Hospital
RECRUITINGTianjin, Tianjin Municipality, 300384, China
Contact Phone: •••-•••-•••• Email: •••••@•••••